Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 317

Results For "PLI"

3556 News Found

Thermo Fisher Scientific’s new CRISPR Genome editing protein
Biotech | November 30, 2021

Thermo Fisher Scientific’s new CRISPR Genome editing protein

Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications


ZenOnco.io raises US $ 1.4 mn in seed funding
Startup | November 29, 2021

ZenOnco.io raises US $ 1.4 mn in seed funding

The funds will be used to scale up existing operations and launch new products


Bharat Biotech commences export of Covaxin
News | November 29, 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart


Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets


Sputnik Light in India by December: RDIF
News | November 25, 2021

Sputnik Light in India by December: RDIF

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


Air pollution reduces life expectancy by eight years in India
News | November 25, 2021

Air pollution reduces life expectancy by eight years in India

India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution


Gastrointestinal disorders increasing in India
Public Health | November 25, 2021

Gastrointestinal disorders increasing in India

It is estimated that one-third of our country’s population has some form of these disorders


Medical devices industry needs reforms:  Mehernosh Daruwalla, Founder & MD, Lotus Surgicals
interviews | November 24, 2021

Medical devices industry needs reforms: Mehernosh Daruwalla, Founder & MD, Lotus Surgicals

The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector


U.S. FDA approves first treatment for drug-resistant post-transplant infection
Drug Approval | November 24, 2021

U.S. FDA approves first treatment for drug-resistant post-transplant infection

The approval is for Cytomegalovirus, a type of Herpes virus